Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.

The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Abstract Text:

    norah j shireNorah J Shire,susan d rousterSusan D Rouster,sandra d stanfordSandra D Stanford,jason t blackardJason T Blackard,christina m martinChristina M Martin,carl j fichtenbaumCarl J Fichtenbaum,kenneth e shermanKenneth E Sherman,

    BACKGROUND: Occult hepatitis B virus (HBV) is defined as low-level HBV DNA without hepatitis B surface antigen (HBsAg). Prevalence estimates vary widely. We determined the prevalence of occult HBV at the University of Cincinnati Infectious Diseases Center (IDC). METHODS: Patients in the IDC HIV database (n = 3867) were randomly selected using a 25% sampling fraction. Samples were pooled for HBV nucleic acid extraction. Pools were tested for HBV DNA by a real-time polymerase chain reaction (PCR) assay to co-amplify core/surface protein regions. The PCR assay was run on all individual samples from each DNA pool. DNA samples were tested for HBV serologic markers. RESULTS: A total of 909 patients without known HBV were selected. The mean CD4 count was 384 cells/mm. Forty-three patients were HBV DNA. Twelve of 43 were DNA/HBsAg (95% confidence interval for database: 0.58% to 1.90%). Five of 12 were negative for all serologic markers. Alanine aminotransferase, aspartate aminotransferase, and HBV DNA titers were elevated in HBsAg patients versus occult patients and versus HIV-monoinfected patients. No other significant differences were detected. No occult HBV patient was on treatment with anti-HBV activity. CONCLUSIONS: Forty-three percent of those with HBV were not previously identified as HBV, indicating the need for ongoing screening in high-risk populations. Occult HBV may occur in persons with all negative serologic markers, representing a challenge for identification.

    The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Publishing Authors By Initials

    nj shireNJ Shire,sd rousterSD Rouster,sd stanfordSD Stanford,jt blackardJT Blackard,cm martinCM Martin,cj fichtenbaumCJ Fichtenbaum,ke shermanKE Sherman,

    For similar investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of acquired immune deficiency syndromes (1

    VOLUME: 44

    Page Numbers: 309-14

    Journal Abbreviation: J. Acquir. Immune Defic. Syndr

    ISSN: 1525-4135

    DAY: 1

    MONTH: Mar

    YEAR: 2007

    The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100892005

    The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Keywords Mesh Terms:

    KEYWORDS: Risk Factors

    MESH TERMS: epidemiology

    Chemical & Substance for Abstract: The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Information

    Substance Name: Alanine Transaminase

    Registry Number: EC 2.6.1.2

    Grant and Affiliation Information for The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.

    AFFILIATION: Division of Digestive Diseases, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. norah.shire@uc.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: AI 25897

    ACRONYM: AI

    MEDLINETA: J Acquir Immune Defic Syndr

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News